Cargando…
HER2 Amplification in p53-Mutated Endometrial Carcinomas
SIMPLE SUMMARY: Endometrial cancers with p53 mutations tend to recur and develop metastases more frequently. From this point of view, the detection of new potential therapeutic targets such as HER2 is particularly interesting. In this study, we demonstrated that overexpression of HER2 (++ or +++) wa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001224/ https://www.ncbi.nlm.nih.gov/pubmed/36900227 http://dx.doi.org/10.3390/cancers15051435 |